In particular, we examined whether decitabine modified the expressions of genes encoding anti-inflammatory molecules such as Krüppel-like factor-2 (KLF2), since these molecules inhibit osteoclast activity and thus periodontitis-associated alveolar bone loss. Here, KLF2 is linked to periodontitis.